Impact of an HPV Primary Prevention Intervention on HPV Vaccination Rates Among Adolescents in the AuRA Region.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: HPV animation.
- Who it may be relevant to
- Registry conditions: Middle School and High School Students. Basic parameters: 11 years — 17 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Prospective, Randomized, Cluster-controlled, Multicenter Study to Evaluate the Impact of an HPV Primary Prevention Intervention on HPV Vaccination Rates Among Adolescents in the AuRA Region.
Overview
Human papillomaviruses (HPV) are very common contagious viruses: approximately 70% of men and women will be infected during their lifetime. Vaccination, recommended since 2007 for girls and since 2021 for all young people aged 11 to 14 (with catch-up vaccination possible up to age 26), remains insufficiently followed. Today, only 40.7% of adolescents are vaccinated in France, and the Auvergne Rhône Alpes region remains below the targets (47.5% for girls and 12.3% for boys). This is still far from the national target of 80% vaccination coverage by 2030, while 6,400 new cases of HPV-related cancers are reported each year. The PIMCOP regional study aims to assess the impact of a primary prevention intervention, co-developed with stakeholders and implemented in middle and high schools, on the HPV vaccination rate at 6 months among 11-17 year olds.
Interventions
- Behavioral HPV animation
This presentation will enable young people to gather key information about HPV: - What is it? - How is it transmitted? - Who is affected? - What are the possible consequences? - How can you protect yourself? To this end, it was decided to hold a 1.5-hour presentation for 9th grade classes in middle school and 12th grade classes in high school. This presentation consists of a discussion with the students about the five key pieces of information mentioned above, followed by a game to find the loca
Primary outcome measures
- Vaccination [Time frame: Month 6]
Secondary outcome measures (3)
- health literacy level [Time frame: inclusion (Day 0), month 6]
- levels of knowledge about HPV-related risks and other cancer risk factors [Time frame: inclusion (Day 0), month 6]
- acceptability [Time frame: At the end of the intervention, maximum Day 5]
Eligibility criteria
Inclusion Criteria for children :
- Girl or boy, student at a public school participating in the study
- Aged 11 to 17
- Having received an information sheet about the study and having signed a declaration of non-objection
- Whose parents have also received an information sheet and have not expressed their non-objection
- Able to read, write, and understand French
- Affiliated with the SS or equivalent
Exclusion Criteria for children:
- children protected by the law
Inclusion Criteria for teachers :
- Male or female, teacher at a public school participating in the study and supervising a participating class
- Aged 18 or over
- Having received an information sheet about the study and not having expressed their opposition
- Able to read, write, and understand French
- Affiliated with the SS or equivalent
Exclusion Criteria for teachers :
\- Person specially protected by law
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Prevention
Study locations
France · 1 center
- Lycée BELTRAME — Saint-Priest
Identifiers
NCT: NCT07414719 · PIMCOP